Science Explorer Back to mapMap
Discussion
Company · Boulogne-Billancourt · France

Gilead Sciences (France)

gilead.com/about/worldwide-operations/europe/franceROR OpenAlex
Research works
60
▲ 7% vs 2018-21
Citations
840
14.0 per fractional work
Top-10% rate
6.9%
all institutions 10.0%
Open access
36%
world 40%
International
66%
world 18%
Gilead Sciences (France)

Not ranked overall: Gilead Sciences (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Gilead Sciences (France) work in?

In all years, 73% of research at Gilead Sciences (France) is in Health Sciences, 11% in Social Sciences. Its largest fields are Medicine (70%), Biochemistry, Genetics and Molecular Biology (4%), Psychology (4%). It does 2.7× the world's share of Health Sciences.

Health Sciences: 44 fractional works · 72.7% of its workMedicine: 42 fractional works · 69.5% of its workPulmonary and Respiratory Medicine: 4 fractional works · 6.9% of its workCardiology and Cardiovascular Medicine: 4 fractional works · 6.7% of its workHepatology: 4 fractional works · 6.2% of its workEpidemiology: 4 fractional works · 6.2% of its workOncology: 3 fractional works · 5.5% of its workInfectious Diseases: 3 fractional works · 5.2% of its workSurgery: 3 fractional works · 4.7% of its workNeurology: 2 fractional works · 4.1% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 3.2% of its workPathology and Forensic Medicine: 2 fractional works · 2.9% of its workGenetics: 2 fractional works · 2.5% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.5% of its workPsychiatry and Mental health: 1 fractional works · 1.8% of its workPhysiology: 1 fractional works · 1.7% of its workRheumatology: 1 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.4% of its workPharmacology: 1 fractional works · 1.4% of its workHematology: 1 fractional works · 1.3% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.7% of its workFamily Practice: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.5% of its workEmergency Medicine: 0 fractional works · 0.5% of its workNephrology: 0 fractional works · 0.4% of its workHealth Professions: 2 fractional works · 2.7% of its workGeneral Health Professions: 2 fractional works · 2.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 0.0% of its workSocial Sciences: 7 fractional works · 11.3% of its workPsychology: 2 fractional works · 3.9% of its workClinical Psychology: 2 fractional works · 2.7% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.6% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 3.3% of its workCommunication: 1 fractional works · 1.7% of its workSociology and Political Science: 1 fractional works · 1.6% of its workArts and Humanities: 1 fractional works · 1.8% of its workHistory and Philosophy of Science: 1 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 1.7% of its workStrategy and Management: 1 fractional works · 1.7% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workEconomics and Econometrics: 0 fractional works · 0.6% of its workLife Sciences: 6 fractional works · 9.3% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 4.4% of its workMolecular Biology: 1 fractional works · 2.4% of its workCancer Research: 1 fractional works · 0.9% of its workClinical Biochemistry: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 2 fractional works · 2.9% of its workVirology: 1 fractional works · 1.4% of its workImmunology: 1 fractional works · 1.2% of its workParasitology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNeuroscience: 1 fractional works · 1.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.9% of its workToxicology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.0% of its workPhysical Sciences: 4 fractional works · 6.8% of its workChemistry: 2 fractional works · 3.0% of its workOrganic Chemistry: 2 fractional works · 2.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 1 fractional works · 1.4% of its workTheoretical Computer Science: 0 fractional works · 0.8% of its workStatistics and Probability: 0 fractional works · 0.5% of its workPhysics and Astronomy: 1 fractional works · 1.1% of its workAstronomy and Astrophysics: 1 fractional works · 1.1% of its workEngineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workALL ITS WORKGilead Sciences(France)60fractional works, all years
Life Sciences9%Physical Sciences7%Health Sciences73%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine4269.5%
    2. Health Professions22.7%
    3. Nursing00.4%
    4. Veterinary00.0%
    1. Psychology23.9%
    2. Social Sciences23.3%
    3. Arts and Humanities11.8%
    4. Business, Management and Accounting11.7%
    5. Economics, Econometrics and Finance00.6%
    1. Biochemistry, Genetics and Molecular Biology34.4%
    2. Immunology and Microbiology22.9%
    3. Neuroscience11.0%
    4. Pharmacology, Toxicology and Pharmaceutics10.9%
    5. Agricultural and Biological Sciences00.0%
    1. Chemistry23.0%
    2. Mathematics11.4%
    3. Physics and Astronomy11.1%
    4. Engineering00.6%
    5. Computer Science00.5%
    6. Materials Science00.1%
    7. Environmental Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.79× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 6.05× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 0.88× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.99× its world share, 0 worksChemistryComputer Science: 0.32× its world share, 0 worksComputer ScienceEngineering: 0.08× its world share, 0 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMathematics: 1.67× its world share, 0 worksMathematicsHealth Professions: 0.10× its world share, 0 worksHealth ProfessionsMedicine: 3.89× its world share, 9 worksMedicineArts and Humanities: 0.19× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.59× its world share, 0 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychologySocial Sciences: 0.22× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.0×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Immunology and Microbiology6.05×1 works
  2. Medicine3.89×9 works
  3. Chemistry1.99×0 works
  4. Mathematics1.67×0 works
  5. Pharmacology, Toxicology and Pharmaceutics0.88×0 works
  6. Biochemistry, Genetics and Molecular Biology0.79×0 works
  7. Economics, Econometrics and Finance0.59×0 works
  8. Computer Science0.32×0 works
  9. Social Sciences0.22×0 works
  10. Arts and Humanities0.19×0 works
  11. Environmental Science0.10×0 works
  12. Health Professions0.10×0 works
  13. Engineering0.08×0 works
  14. Psychology0.05×0 works
  15. Business, Management and Accounting0.04×0 works
  16. Agricultural and Biological Sciences0.03×0 works

Who are the top researchers at Gilead Sciences (France)?

Ranked on the quality score, O. Libert lead among researchers whose main affiliation is Gilead Sciences (France).

  1. 1 O. Libert France · #3,584,964 worldwide 152 citations · 23 works
All ranked researchers at Gilead Sciences (France)

What are the most cited papers from Gilead Sciences (France)?

The most cited paper from Gilead Sciences (France) is "KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma" (Michael Wang et al., 2020), with 1,874 citations. Next come "Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy" (384) and "Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies" (194).

Most cited papers
#PaperReleasedCitations
1 KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma Michael Wang et al. · New England Journal of Medicine Open access Apr 2020 1,874
2 Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy Jürgen Kurt Rockstroh, Amanda Mocroft, Vincent Soriano et al. · The Journal of Infectious Diseases Open access 19 Aug 2005 384
3 Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies Denis Caillot, Anne Thiébaut, Raoul Herbrecht et al. · Cancer Open access 16 Oct 2007 194
4 Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine Lukas Radbruch, Rainer Sabatowski, Georg Loick et al. · Palliative Medicine Mar 2000 145
5 Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis Tilman Polster · Journal of Neurology Neurosurgery & Psychiatry Open access Apr 2001 143
All 61 most cited papers, with filters and sorting

Which keywords describe research at Gilead Sciences (France)?

By fractional works in all years, weighted toward what it does more of than the world: Treatment, Immune Response, Hypertension, Global Burden, Epidemiology, Liver Disease, Antiviral Therapy and Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology7▲ 2.8×31 topics
  2. Treatment6▲ 8.3×17 topics
  3. Immune Response5▲ 14×9 topics
  4. Hypertension4▲ 20×6 topics
  5. Cardiovascular Disease4▲ 6.1×11 topics
  6. Global Burden4▲ 13×8 topics
  7. Antiviral Therapy4▲ 43×3 topics
  8. Liver Disease4▲ 48×3 topics
  9. Immunotherapy4▲ 9.8×11 topics
  10. Cardiovascular Events4▲ 38×4 topics
  11. Antiretroviral Therapy4▲ 26×5 topics
  12. Lymphoma3▲ 38×3 topics
  13. Diagnosis3▲ 4.9×11 topics
  14. Hepatitis C Virus3▲ 88×1 topic
  15. Ribavirin3▲ 88×1 topic
  16. Clinical Guidelines3▲ 14×4 topics
  17. Risk Factors3▲ 4.3×5 topics
  18. Drug Resistance2▲ 13×5 topics
  19. Blood Pressure2▲ 58×2 topics
  20. Diabetes Mellitus2▲ 17×2 topics
  21. Hepatocellular Carcinoma2▲ 18×3 topics
  22. Prognostic Factors2▲ 8.7×8 topics
  23. Antihypertensive Drugs2▲ 69×1 topic
  24. Cancer Immunotherapy2▲ 27×2 topics
  25. Heart Failure2▲ 8.3×5 topics
  26. Renal Denervation2▲ 69×1 topic
  27. Innovation2▲ 4.1×3 topics
  28. Metabolic Syndrome2▲ 4.3×4 topics
  29. Tumor Regression2▲ 42×2 topics
  30. CAR T Cells2▲ 81×1 topic
  31. Chimeric Antigen Receptor2▲ 81×1 topic
  32. Rituximab2▲ 21×2 topics
  33. Classification2▲ 8.7×2 topics
  34. HIV Infection2▲ 23×2 topics
  35. PET Imaging2▲ 13×4 topics
  36. Hepatotoxicity2▲ 34×2 topics
  37. Radiosurgery2▲ 27×4 topics
  38. Integrase Inhibitors1▲ 56×1 topic
  39. Nucleoside Analogues1▲ 56×1 topic
  40. Neurological Complications1▲ 30×2 topics

Which research topics does Gilead Sciences (France) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Electrolyte and hormonal disorders, Biotechnology and Related Fields and Lymphoma Diagnosis and Treatment.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksElectrolyte and hormonal disorders: 1 fractional worksBiotechnology and Related Fields: 1 fractional worksLymphoma Diagnosis and T…1Lymphoma Diagnosis and Treatment: 1 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksHIV/AIDS drug development and treatment: 0 fractional worksHepatitis C virus research: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksHIV/AIDS Research and Interventions: 0 fractional works
OncologyPulmonary and Respiratory MedicinePublic Health, Environmental and Occupational HealthPathology and Forensic Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 1 works
  3. 3 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 0 works
  6. 6 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  7. 7 Hepatitis C virus research Hepatology 0 works
  8. 8 Breast Cancer Treatment Studies Cancer Research 0 works
  9. 9 Chronic Lymphocytic Leukemia Research Genetics 0 works
  10. 10 HIV/AIDS Research and Interventions Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.8%not open64.2%

World: 40% of research is openly available.

with international co-authors65.9%domestic only34.1%

World: 18% is written across borders.

How has Gilead Sciences (France)'s research output changed?

Output in 2022-2025 was 7% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Gilead Sciences (France) as a percentage of every work published that year, 0.000053% in 2024.

still counting0.00020%0.00040%Gilead Sciences (France)0.000060% in 20251990200020102020

Fractional works of Gilead Sciences (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Boulogne-Billancourt

All research institutions in Boulogne-Billancourt

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Gilead Sciences (France). Posts are plain text and can be reported.